PubMedCrossRef 10. Haukioja A: Probiotics and oral health. Eur J Dent 2010, 4:348–355.PubMed 11. Simark-Mattsson C, Emilson CG, Hakansson EG, Jacobsson C, Roos K, Holm S: Lactobacillus -mediated interference of mutans streptococci in caries-free vs. caries-active subjects. Eur J Oral Sci 2007, 115:308–314.PubMedCrossRef 12. Kanasi E, Johansson I, Lu SC, Kressin NR, Nunn ME, Kent R Jr, Tanner AC: YH25448 nmr Microbial risk markers for childhood caries in pediatricians’

offices. J Dent Res 2010, 89:378–383.PubMedCrossRef 13. Holgerson PL, Vestman NR, Claesson R, Ohman C, Domellof M, Tanner AC, Hernell O, Johansson I: Oral microbial profile discriminates breast-fed from formula-fed infants. J Pediatr Gastroenterol Nutr 2013, 56:127–136.PubMedCrossRef 14. Straetemans MM, van Loveren C, de Soet JJ, de Graaff J, ten Cate JM: Colonization with mutans streptococci and lactobacilli and the caries PX-478 experience of children after the age of five. J Dent Res 1998, 77:1851–1855.PubMedCrossRef 15.

Martin R, Langa S, Reviriego C, Jiminez E, Marin ML, Xaus J, Fernandez L, Rodriguez JM: Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 2003, 143:754–758.PubMedCrossRef 16. Solis G, de Los Reyes-Gavilan CG, Fernandez N, Margolles A, Gueimonde M: Establishment and development of lactic acid bacteria and bifidobacteria microbiota in breast-milk and the selleck infant gut. Anaerobe 2010, 16:307–310.PubMedCrossRef 17. Aimutis WR: Bioactive properties of milk proteins with particular focus on anticariogenesis. J Nutr 2004, 134:989–995. 18. Danielsson Niemi L, Hernell O, Johansson I: Human milk compounds inhibiting adhesion of mutans streptococci to host ligand-coated hydroxyapatite in vitro. Caries Res 2009, 43:171–178.PubMedCrossRef 19. Wernersson J, Danielsson Niemi L, Einarson S, Hernell O, Johansson I: Effects of human milk on adhesion

of Streptococcus mutans to saliva-coated hydroxyapatite in vitro. Caries Res 2006, 40:412–417.PubMedCrossRef 20. Ballard O, Morrow AL: Human milk composition: nutrients and bioactive Oxymatrine factors. Pediatr Clin North Am 2013, 60:49–74.PubMedCrossRef 21. Liao Y, Alvarado R, Phinney B, Lonnerdal B: Proteomic characterization of human milk fat globule membrane proteins during a 12 month lactation period. J Proteome Res 2011, 10:3530–3541.PubMedCrossRef 22. Cavaletto M, Giuffrida MG, Conti A: Milk fat globule membrane components–a proteomic approach. Adv Exp Med Biol 2008, 606:129–141.PubMedCrossRef 23. Charlwood J, Hanrahan S, Tyldesley R, Langridge J, Dwek M, Camilleri P: Use of proteomic methodology for the characterization of human milk fat globular membrane proteins. Anal Biochem 2002, 301:314–324.PubMedCrossRef 24. Lonnerdal B: Bioactive proteins in breast milk. J Paediatr Child Health 2013,49(Suppl 1):1–7.PubMedCrossRef 25. Brisson G, Payken HF, Sharpe JP, Jimenez-Flores R: Characterization of Lactobacillus reuteri interaction with milk fat globule membrane components in dairy products.